OUTCOME OF TREATMENT FOR OAT SYNDROME BY INTRACYTOPLASMIC SPERM INJECTION AT THE ART CENTER

Similar documents
Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

MSOME I+II: A NEW CUT-OFF VALUE FOR MALE INFERTILITY AND EMBRYO DEVELOPMENT PREDICTION ON INTRACYTOPLASMIC SPERM INJECTION CYCLES

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

INDICATIONS OF IVF/ICSI

Novel Technologies for Selecting the Best Sperm for IVF and ICSI

Understanding IVF Processes in Surrogacy

Adoption and Foster Care

Selection of sperm for ICSI: hyaluronan binding

Reproductive Technology, Genetic Testing, and Gene Therapy

IVF MONEY-BACK PLAN. More information about payment options? IN PARTNERSHIP WITH. Call Access Fertility or visit their website

SpermComet DNA Test your results and what they mean

THE INFLUENCE OF EJACULATORY ABSTINENCE INTERVALS ON SEMEN QUALITY - OLD CONCEPT, NEW EVIDENCES

Results and Discussion

Hold On To Your Dreams

Biology of fertility control. Higher Human Biology

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

Possibilities Plan. Access to the care you need.

Infertility treatment

THE SUCCESS RATE PLACE US AMONG THE BEST IVF CENTERS IN THE WORLD

Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS

Male Fertility: Your Questions Answered

East and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception

Fertility treatment and referral criteria for tertiary level assisted conception

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

Dr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New?

Fertility treatment and referral criteria for tertiary level assisted conception

Bank your future: Insemination and semen cryopreservation. Disclosure. Lecture objectives

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

1 - Advanced clinical course for ART with Hands on

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

M Magdy EL-Sheikh FRCOG London, FRCS Glasgow Director ART unit Dr Soliman Fakeeh hospital Jeddah Saudi Arabia

Recommended Interim Policy Statement 150: Assisted Conception Services

FIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Société Suisse de Médecine de la Reproduction

Use of donor semen in the treatment of

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019

European IVF Monitoring (EIM) Year: 2013

IVF: PAST, PRESENT AND FUTURE

Problem Challenge Need. Solution Innovation Invention

Introduction. Introduction. Assisted reproduction using donor sperm bank IUI IVF ICSI. Andrology Laboratory IVI Madrid. Dr.

WHAT IS A PATIENT CARE ADVOCATE?

Pronuclear morphology evaluation for fresh in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) cycles: a systematic review

Fertility Services Commissioning Policy

INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018

LCCG Fertility Services Commissioning Policy

Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization

Fertility Services Commissioning Policy

Rejuvenation of Gamete Cells; Past, Present and Future

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

Information Sheet. Male Infertility

Fertility What do GP s need to know? Richard Fisher Fertility Associates

Sample size a Main finding b Main limitations

SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs)

Number of oocytes and live births in IVF

Laura Rienzi Senior Clinical Embryologist

European IVF Monitoring (EIM) Year: 2012

IN VITRO FERTILISATION (IVF)

Prepare your first visit to Sakthi Fertility

Health Service System City & County of San Francisco

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial

Fertility Services Commissioning Policy

Dr Manuela Toledo - Procedures in ART -

Preimplantation Genetic Diagnosis (PGD) in Western Australia

Cycle Plan Page1 CYCLE PLAN TYPE CYCLE TYPE: Initial Plan Updated Plan Management Team Review Monitoring Review

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler

INFERTILITY SERVICES

Should ICSI be implemented during IVF to all advanced-age patients with non-male factor subfertility?

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

Article Influence of spermatogenic profile and meiotic abnormalities on reproductive outcome of infertile patients

Patient selection criteria for blastocyst culture in IVF/ICSI treatment

to ensure the. Sexual reproduction requires the (from the mother) by a (from the father). Fertilization is the fusion of.

Abstract. Introduction. Materials and methods. Patients and methods

Optimize your success

The Impact of ESHRE 2017 on Japanese Fertility Practice

Myths About Success Rates Do they truly reflect quality of care

In this document, you will find information about donor screening and selection and all forms needed to reserve and purchase your eggs.

Increase your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)

CLINICAL RESULTS 2016

Egg Sharing Price list

Testosterone Therapy-Male Infertility

Support for Fertility and Infertility Treatment

Welcome. Fertility treatment can be complicated. What s included. Your fertility treatment journey begins here. Fertility treatment basics 2

Sperm Function Tests Beyond the Semen Analysis

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

Derived copy of Fertilization *

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services

Embryo Selection after IVF

Yes infertility policy pdf

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES

Clinical Policy Committee

Planning for Parenthood After a Cancer Diagnosis

IVF. NHS North West London CCGs

LISI CARRIERS INFERTILITY COMPARISON

Curriculum Vitae. Personal Information. In the name of God. First name: Zahra Last name: Shams Mofarahe

Hold On To Your Dreams. Understanding IVF Process In Surrogacy The Basics

Brighton & Hove CCG PLS CONFERENCE Dr Carole Gilling-Smith Medical Director

The beginning of puberty is marked by the progressive increase in the production of sex hormones.

Fertility Services Commissioning Policy

Patient Overview: Invitro Fertilisation

Top 10 questions in fertility

Transcription:

OUTCOME OF TREATMENT FOR OAT SYNDROME BY INTRACYTOPLASMIC SPERM INJECTION AT THE ART CENTER Ho Sy Hung, Trinh Thi Thuy Hanoi Medical University, Thaibinh Medical University

INTRODUCTION Infertility rate in the world: 8%-12% (60-80 million people) Tremellen: 1/20 men are involved in infertility OAT accounted for 34.6% male infertility

INTRODUCTION ICSI: Palermo reported the first case in 1992 Just 1 sperm is enough to fertilize with 1 oocyte Fertilization rate 70%. The effect of ICSI with severe abnormal sperm (OAT syndrome)?

OBJECTIVE Evaluate the outcome of treatment for OAT syndrome by Intracytoplasmic Sperm Injection at the Assited Reproductive Technology Central

BACKGROUND OAT (oligo-astheno-teratozoospermia): total number (or concentration) of spermatozoa, percentages of both progressive (PR),& normal morphology spermatozoa, below lower reference limits (WHO 2010). Pang (1999): OAT males were high rates of chromosome disomy Liu (2004): spermatozoa in OAT patients contain DNA fragmentation, mitochondrial dysfunction, chromosomal aneuploidy compare with normozoospermic patients affects capability of sperm to activate egg trigger formation & development of normal zygote Low fertilization & pregnancy rates.

BACKGROUND Aurélie Charpuis et al (2017): In ICSI cycles Lower the sperm concentration lower fertilization & formation rate. Fertilization rate reduced in PR < 32% group compare to PR > 32% group James M Hotaling (2010): Isolated teratozoospermia was not associated with pregnancy rate. Sidney Verza (2008): in ICSI cycles fertilization rate, blastocyst formation and pregnancy rate in OAT patients were lowest compare to normal spermogram, single or double spermogram index abnormal group.

MATERIALS AND METHODS Retrospective study from 01/2015 12/2016, 140 infertility couples due to husband having OAT were IVF/ICSI at the ART Center meet the eligibility criteria: Male Female 35 years old Normal ovarian reserve Progressive motility (PR) < 32% Normal morphology sperm < 4% Normal uterus No hydro-salpinx

RESEARCH PROCESS DIAGRAMS Infertile couples due to husband having OAT fit the selection criteria (n = 140) First IVF/ICSI cycle (n = 140) Clinical pregnancy (n= 73) Non-clinical pregnancy (n = 67) 2 nd IVF/ICSI cycle (n = 20) Clinical pregnancy (n = 4) Non-clinical pregnancy (n= 16) 3 rd IVF/ICSI (n = 4) Clinical pregnancy (n = 3) Non-clinical pregnancy (n = 1)

MATERIALS AND METHODS Study variables and indexes Patient characteristics Male & female age, infertility duration, semen parameters Results of IVF/ICSI ICSI: number of retrieved oocytes, number of ICSI oocytes, fertilization rate per oocyte, number of embryos Embryo transfer: number of transfer embryos, implantation rate, pregnancy rate, number of pregnancies Pregenancy: pregnancy progresses, give birth, miscarriage, GEU

Age groups RESULTS 60.0% 50.0% 40.0% 30.0% 20.0% 19.3% 52.9% 38.6% 37.9% 27.9% 18.6% Female age Male age Mean SD: Female age: 28.43 3.2 Male age: 32.22 4.3 10.0% 0.0% 2.9% 0% 0% 2.1% 20-25 26-30 31-35 36-40 41 Years old Bhilawadikar R: female age 34.4 0.2; male age: 34.1 0.3. Turhan N: female age: 28.97 3.7 28.82 4.0 male age: 33.05 5.3 32.55 4.7

CHARACTERISTICS OF THE RESEACH OBJECT Infertility duration 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% 59.3% 37.9% 2.9% Mean 4.46 2.9 < 5 5-10 > 10 Years SD: Ho Sy Hung: 3.97 3.4. Han Manh Cuong: 5.1 3.6 6.0 3.4. Turhan N: 5.21 3.6 4.68 2.9

CHARACTERISTICS OF THE RESEACH OBJECT Sperm concentration 40.0% 35.0% 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% Sperm concentration 33.6% Mean SD: 5.70 4.4 Min Max : 0.1 14 27.9% 25% 13.6% < 1 1 - < 5 5 - < 10 10 - < 15

CHARACTERISTICS OF THE RESEACH OBJECT Sperm count 50.0% 40.0% 45.7% Sperm count Mean SD:13.85 11.6 Min Max: 0.25 36 30.0% 25% 20.0% 10.0% 0.0% 13.6% 15.7% < 10 10 - < 20 20 - < 30 30 - < 39 Bhilawadikar R (2013): 10.3 0.4

CHARACTERISTICS OF THE RESEACH OBJECT Progressive motility 40.0% 35.0% 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% 14.3% 23.6% 25% 37.1% 0% 1-10% 11-20% 21 - < 32% Bhilawadikar R (2013): 7.5 0.4 Mean SD: 15.67 11.9 Min Max: 0 31

CHARACTERISTICS OF THE RESEACH OBJECT Normal morphology sperm 100.0% 90.0% 80.0% 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% 88.6% 10% Normal morphology sperm 1.4% 0% 1% 2%

RESULTS OF ICSI & EMBRYO TRANSFER According to sperm concentration 0,2 (n=10) 0,2 5 (n=73) 5 < 15 (n=57) General (n=140) No. of cycles 15 85 64 164 No. of oocytes ICSI 10.73 3.4 9.39 5.3 11.47 6.5 10.32 5.7 0.08 No. of fertilization oocytes 8.53 3.2 7.53 4.8 9.27 4.8 8.30 4.7 0.081 Fertilization rate (%) 79.66 16.8 81.33 20.7 83.26 15.5 81.93 18.5 0.73 No. of embryos formation No. of transferred embryos 8.07 3.4 6.55 3.8 8.38 4.4 7.40 4.1 0.021 3.09 0.8 3.05 0.8 3.16 0.8 3.10 0.7 0.54 Implantation rate (%) 7.58 15.0 13.71 22.1 22.49 27.0 16.53 24.1 0.007 Clinical pregnancies (n, %) 4 (26.67%) 36 (42.35%) 40 (62.5%) 80 (48.78%) 0.027 - Fertilization rate (%): Aurélie Charpuis 58.3; 61.9; 65.3; p< 0.0001; Hyung Jun Kim 65.0 21.1 67.7 19.9. Sidney Verza 63.4 26.9. - Clinical pregnancies rate (%) - Aurélie Charpuis 35.3; 41.3; 39.6; p > 0.05. p

RESULTS OF ICSI & EMBRYO TRANSFER According to progressive motility Index PR (%) 0 (n=20) 1 10 (n=57) 11 20 (n=23) 21 < 32 (n=40) No. of cycles 24 63 30 47 No. of oocytes ICSI 12.29 5.2 10.75 6.2 8.87 4.4 9.68 5.8 0.12 No. of fertilization oocytes 9.29 4.3 8.48 5.2 7.70 4.3 7.94 4.5 0.59 Fertilization rate (%) 78.39 21.0 79.07 19.4 86.45 18.3 84.67 15.4 0.16 No. of embryos formation No. of transferred embryos 7.92 3.5 7.44 4.4 6.63 3.3 7.56 4.4 0.68 3.21 0.8 3.06 0.7 3.03 0.8 3.11 0.7 0.72 Implantation rate (%) 14.32 23.9 18.87 24.0 18.80 26.6 13.58 22.7 0.51 Clinical pregnancies (n, %) 12 (50%) 34 (53.97%) 15 (50%) 19 (40.43%) 0.23 p

RESULTS OF ICSI & EMBRYO TRANSFER According to morphology sperm Index Morphology sperm Non normal morphology sperm Have normal morphology sperm p No. of cycles 148 16 No. of oocytes ICSI 10.48 5.9 8.88 3.1 0.087 No. of fertilization oocytes 8.39 4.9 7.44 2.2 0.169 Fertilization rate (%) 81.54 18.9 85.50 14.3 0.418 No. of embryos formation 7.46 4.3 6.88 2.3 0.389 No. of transferred embryos 3.10 0.8 3.10 0.6 0.984 Implantation rate (%) 14.78 22.8 33.75 29.8 0.011 Clinical pregnancies (n, %) 68 (45.95%) 13 (81.25%) 0.007

RESULTS OF CLINICAL PREGNANCY After each pick up ovum cycles Clinical pregnancy (n; %) Total Fresh embryos transfer (n = 137) First cycle (n = 115) 49 (42.61%) 2rd cycle (n = 19) 4 (21.05%) 3nd cycle (n = 3) 1 (33.33%) Frozen embryos transfer (n = 80) 26 (32.5%) Cumulative pregnancy 80 (48.78%) Bhilawadikar R: 12.12%. Turhan N: 47.5%. Hyung Jun Kim: 12.5% - 33%. Calogero: 39%. Sidney Verza: 51% 54 (39.42%)

RESULTS OF CLINICAL PREGNANCY Cumulative pregnancy rate/patients after 3 cycles IVF/ICSI 58.00% 57.00% 56.00% 55.00% 54.00% 53.00% 52.00% 51.00% 50.00% 49.00% First cycle 52.14% 55% 57.14% 2rd cycle 3nd cycle Clinical pregnancy rate Ho Sy Hung (2014): 38.8%; 46.47%; 48.24%

RESULTS OF CLINICAL PREGNANCY Pregnancy gestation Results Number Percen (%) Pregnancy progresses 23 28.8 Give birth 39 48.7 Miscarriages 14 17.5 GEU 4 5.0 Total 80 100 Ho Sy Hung: pregnancy progresses + give birth= 86.1% (ours: 77.7%), miscarriages: 13.9% (17.5%)

CONCLUSION Mean fertilied oocytes was of : 8.30 4.7 Mean fertilization rate : 83.21 25.2% Average implantation rate was : 16.76 24.2% The clinical pregnancy rate: 48.78% & cumulative pregnancy rate: 57.14% Number of embryos formation, implantation rate, rerults of clinical pregnancies related to sperm concentration & morphology